• EV-Transferred ACLY Drives TAM Differentiation in Hepatocell

  2026-07-22

  This study identifies extracellular vesicle-mediated transfer of ATP-citrate lyase (ACLY) from hepatocellular carcinoma (HCC) cells to monocytes as a key mechanism driving their differentiation into tumor-associated macrophages (TAMs). The work elucidates how EV-delivered ACLY enhances immune checkpoint protein stability, fueling HCC progression and offering new metabolic targets for immunotherapy.

• Thioredoxin System Governs CHK1 Inhibitor Sensitivity in NSC

  2026-07-21

  This study identifies the thioredoxin (Trx) system as a critical determinant of CHK1 inhibitor sensitivity in non-small cell lung cancer (NSCLC), acting through redox-mediated regulation of ribonucleotide reductase and deoxynucleotide pools. The findings offer a mechanistic basis for combining redox pathway modulation with DNA damage response inhibitors to enhance therapeutic efficacy while potentially reducing toxicity.

• Silymarin Power: Applied Silybin A for Liver & Metabolic Res

  2026-07-21

  Silybin A, the core bioactive in Silymarin, delivers high-purity, reproducible results in liver, metabolic, and inflammation research. Discover how to optimize workflows using APExBIO’s Silybin A, tackle solubility and protocol challenges, and leverage new gene-editing insights to advance translational assays.

• EV-Delivered ACLY Drives Immunosuppressive TAMs in HCC Progr

  2026-07-20

  This study reveals that hepatocellular carcinoma (HCC) cells secrete extracellular vesicles containing ATP-citrate lyase (ACLY), which reprogram monocytes into immunosuppressive tumor-associated macrophages (TAMs). By elucidating the metabolic and signaling pathways underpinning TAM differentiation, the work highlights a promising avenue for improving immunotherapeutic strategies in HCC.

• Direct Mouse Genotyping Kit Plus: Streamlining Genomic Assay

  2026-07-20

  The Direct Mouse Genotyping Kit Plus revolutionizes mouse genetic workflows by enabling rapid, purification-free DNA extraction and direct PCR. Its integrated PCR master mix with dye reagents boosts accuracy and throughput, empowering researchers in transgene detection, gene knockout validation, and complex lineage-tracing studies.

• 25-Hydroxycholesterol Drives Immunosuppressive Macrophage Re

  2026-07-19

  Xiao et al. (2024) reveal a novel mechanism by which 25-hydroxycholesterol (25HC) accumulates within lysosomes of tumor-associated macrophages (TAMs), triggering AMPK activation and STAT6-mediated immune regulation. This metabolic pathway shapes macrophage immunosuppression and impacts tumor immune response, with implications for improving anti-tumor therapies.

• EV-Transferred ACLY Drives TAM Differentiation in HCC Progre

  2026-07-18

  This study reveals how hepatocellular carcinoma cells use extracellular vesicles to transfer ATP-citrate lyase (ACLY) into monocytes, promoting their differentiation into tumor-associated macrophages (TAMs) with immunosuppressive properties. The findings highlight a pivotal metabolic mechanism in tumor progression and suggest that targeting EV-mediated ACLY may enhance immunotherapy efficacy.

• Firefly Luciferase mRNA: Enhanced Reporter for Robust Assays

  2026-07-17

  Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) delivers unparalleled sensitivity and reproducibility in gene expression, viability, and in vivo imaging assays. Its advanced modifications—ARCA capping, 5mCTP, and pseudouridine—translate into superior stability, low immunogenicity, and consistent protein output, making it a gold standard control for modern molecular biology workflows.

• FXR Protein LLPS Organizes Replication Organelles in β-Coron

  2026-07-17

  Li et al. (2024) reveal that fragile X–related (FXR) proteins drive the clustering of double-membrane vesicles (DMVs) for efficient β-coronavirus replication by liquid–liquid phase separation (LLPS). This study uncovers a novel host-pathogen strategy, offering new insights into viral replication organelle dynamics and potential intervention points.

• Ganoderma lucidum Polysaccharide Enhances mRNA-LNP Delivery

  2026-07-16

  This study establishes Ganoderma lucidum polysaccharide (GLP) as a novel adjuvant that enhances mRNA-lipid nanoparticle (LNP) transfection by mitigating oxidative stress, thereby improving protein expression both in vitro and in vivo. The work details a mechanistic link to Nrf2 pathway activation and demonstrates a pragmatic route for increasing mRNA delivery efficiency, with implications for future vaccine and molecular biology applications.

• Dual-Action Modulation of p38α MAPK: Insights from Kinase In

  2026-07-16

  This article critically reviews recent findings demonstrating that certain kinase inhibitors, including BIRB 796 (Doramapimod), not only inhibit p38α MAPK activity but also promote its dephosphorylation by stabilizing specific inactive conformations. These dual-action effects have significant implications for designing selective, potent inhibitors in inflammation and apoptosis research.

• TCF25 Orchestrates Lysosomal Acidification and Cell Death Un

  2026-07-15

  Ren et al. (2025) identify TCF25 as a pivotal nutrient sensor that enhances lysosomal acidification and regulates metabolic adaptation and cell death during glucose starvation. Their study reveals how TCF25-mediated ferritinophagy leads to lysosome-dependent cell death, offering new insights into targeting metabolic and ischemic disorders.

• Gramine Triggers Ferroptosis in TNBC via CUL3–MTDH Axis Cont

  2026-07-15

  This study reveals that gramine, a natural indole alkaloid, suppresses triple-negative breast cancer (TNBC) by activating ferroptosis through CUL3-mediated MTDH ubiquitination. The findings provide mechanistic insight into ferroptosis regulation in TNBC and highlight a potential therapeutic strategy for targeting chemoresistant breast cancer.

• EphA2 as a Synthetic Lethal Target in MYC-Driven TNBC: Chemo

  2026-07-14

  This study introduces a chemogenetic screening platform to identify synthetic lethal vulnerabilities in MYC-driven triple-negative breast cancer (TNBC), revealing EphA2 inhibition as a promising strategy. The findings offer mechanistic insight and preclinical validation for targeting EphA2 in aggressive, MYC-activated TNBC models, independent of p53 status.

• Norovirus Hijacks NINJ1 for Selective Viral Protein Secretio

  2026-07-14

  Song et al. uncover how murine norovirus co-opts the host protein NINJ1 to selectively secrete its NS1 protein, a process dependent on caspase-3 cleavage and distinct from bulk DAMP release. This mechanistic insight redefines our understanding of regulated plasma membrane rupture and viral manipulation of host cell death pathways.

442 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page